This document is available in two formats: this web page (for browsing content) and PDF (comparable to original document formatting). To view the PDF you will need Acrobat Reader, which may be downloaded from the Adobe site. For an official signed copy, please contact the Antitrust Documents Group.

MARC SIEGEL (CSBN 142071)
DANA R. WAGNER (CSBN 209099)
U.S. Department of Justice
Antitrust Division
450 Golden Gate Avenue
Box 36046, Room 10-0101
San Francisco, CA 94102
Telephone: (415) 436-6660

Attorneys for the United States

 

FILED

02 AUG – 7 AM 9: 12

RICHARD W. WIEKING
CLERK, U.S. DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA

 

UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA



UNITED STATES OF AMERICA,    


                  v.


JACQUES JOURDAN

                  Defendant.


)
)
)
)
)
)
)
)
)
)
)
)         
No. CR 02-0234 SI

INFORMATION

VIOLATION:
Title 15, United States Code,
Section 1 (Market-Share
Allocation)

San Francisco Venue

Filed: 08/07/2002



The United States of America, acting through its attorneys, charges:

I.

DESCRIPTION OF THE OFFENSE

1. JACQUES JOURDAN ("JOURDAN") is made a defendant on the charge stated below.

2. Beginning in or about January 1997 and continuing until in or about August 1999, defendant JOURDAN and coconspirators entered into and engaged in a combination and conspiracy to suppress and eliminate competition by allocating the market shares of monochloroacetic acid and sodium monochloroacetate (collectively referred to as "MCAA") to be sold in the United States and elsewhere. The combination and conspiracy engaged in by the defendant and coconspirators was in unreasonable restraint of interstate and foreign trade and commerce in violation of Section 1 of the Sherman Act (15 U.S.C. § 1).

3. The charged combination and conspiracy consisted of a continuing agreement, understanding, and concert of action among the defendant and coconspirators, the substantial term of which was to agree to allocate among major MCAA producers the market shares of MCAA to be sold by each in the United States and elsewhere.

4. For the purpose of forming and carrying out the charged combination and conspiracy, the defendant and coconspirators did those things that they combined and conspired to do, including, among other things:

  1. participating in meetings and conversations to discuss market shares of MCAA to be sold in the United States and elsewhere;
  2. agreeing, during those meetings and conversations, to allocate among major producers of MCAA the market shares of MCAA to be sold in the United States and elsewhere; and
  3. exchanging information on sales of MCAA in the United States and elsewhere for the purpose of monitoring and enforcing adherence to the agreed-upon market shares.

II.

DEFENDANT AND COCONSPIRATORS

5. During the period covered by this Information, defendant JOURDAN was a Department Head of the Chlorine, Vinyl, and Solvents Division of Elf Atochem S.A. ("Elf"), a corporation organized and existing under the laws of France. During the period covered by this Information, the defendant and Elf were engaged in the business of producing MCAA and selling it to customers in the United States and elsewhere.

6. Various corporations and individuals, not made defendants in this Information, participated as coconspirators in the offense charged in this Information and performed acts and made statements in furtherance of it.

7. Whenever in this Information reference is made to any act, deed, or transaction of any corporation, the allegation means that the corporation engaged in the act, deed, or transaction by or through its officers, directors, employees, agents, or other representatives while they were actively engaged in the management, direction, control, or transaction of its business or affairs.

III.

TRADE AND COMMERCE

8. MCAA is a reactive chemical compound that is used to form a number of intermediate chemicals. Markets for MCAA and its derivatives include drilling fluids, plastic stabilizers, herbicides, and pharmaceuticals.

9. During the period covered by this Information, the defendant and coconspirators sold and distributed MCAA in a continuous and uninterrupted flow of interstate and foreign trade and commerce to customers located in states or countries other than the states or countries in which the defendant and coconspirators produced MCAA.

10. The business activities of the defendant and coconspirators that are the subject of this Information were within the flow of, and substantially affected, interstate and foreign trade and commerce.

IV.

JURISDICTION

11. The combination and conspiracy charged in this Information was carried out within the five years preceding the filing of this Information.

ALL IN VIOLATION OF TITLE 15, UNITED STATES CODE, SECTION 1.

Dated: 8-7-02



_______________/s/________________
Charles A. James
Assistant Attorney General


_______________/s/________________
James M. Griffin
Deputy Assistant Attorney General


_______________/s/________________
Scott D. Hammond
Director of Criminal Enforcement



United State Department of Justice
Antitrust Division


_______________/s/________________
Kevin V. Ryan
United States Attorney
Northern District of California

_______________/s/________________
Christopher S Crook
Chief, San Francisco Office


_______________/s/________________
Marc Siegel
Dana R. Wagner

Attorneys
U.S. Department of Justice
Antitrust Division
450 Golden Gate Ave.
Box 36046, Room 10-0101
San Francisco, CA 94102
(415) 436-6660

LK